![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Midas Nintedanib Esylate](https://www.pharmacompass.com/image/flap/midas-nintedanib-esylate-desktop-1gif-89128.gif)
![Midas Nintedanib Esylate](https://www.pharmacompass.com/image/flap/midas-nintedanib-esylate-mob-1gif-18196.gif)
X
01 BOEHRINGER INGELHEIM INT.GMBH (2)
02 Boehringer Ingelheim (Schweiz) GmbH (2)
03 Boehringer Ingelheim International GmbH (5)
01 Vargatef (9)
01 Italy (2)
02 Norway (5)
03 Switzerland (2)
01 Capsule (2)
02 Capsule, soft (5)
03 Nintedanib 100Mg 60 Units Oral Use (1)
04 Nintedanib 150Mg 60 Units Oral Use (1)